DE122006000049I1 - Verwendung von Daptomycin - Google Patents

Verwendung von Daptomycin

Info

Publication number: DE122006000049I1
Authority: DE; Germany
Prior art keywords: daptomycin; administering; muscle toxicity; skeletal muscle; effective amount
Prior art date: 1998-09-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

DE1999630758

Other languages

English (en)

Other versions

DE69930758D1 (de

DE69930758T2 (de

Inventor

B Oleson

P Tally

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cubist Pharmaceuticals LLC

Original Assignee

Cubist Pharmaceuticals LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-25

Filing date

1999-09-24

Publication date

2007-01-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26798675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122006000049(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-09-24 Application filed by Cubist Pharmaceuticals LLC filed Critical Cubist Pharmaceuticals LLC

2007-01-04 Publication of DE122006000049I1 publication Critical patent/DE122006000049I1/de

Status Pending legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)

DE1999630758 1998-09-25 1999-09-24 Verwendung von Daptomycin Pending DE122006000049I1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10182898P	1998-09-25	1998-09-25
US12575099P	1999-03-24	1999-03-24
PCT/US1999/022366 WO2000018419A2 (en)	1998-09-25	1999-09-24	Methods for administration of antibiotics

Publications (1)

Publication Number	Publication Date
DE122006000049I1 true DE122006000049I1 (de)	2007-01-04

Family

ID=26798675

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DE1999630758 Pending DE122006000049I1 (de)	1998-09-25	1999-09-24	Verwendung von Daptomycin
DE200612000049 Active DE122006000049I2 (de)	1998-09-25	1999-09-24	Verwendung von Daptomycin
DE69930758T Expired - Lifetime DE69930758T2 (de)	1998-09-25	1999-09-24	Verwendung von daptomycin

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DE200612000049 Active DE122006000049I2 (de)	1998-09-25	1999-09-24	Verwendung von Daptomycin
DE69930758T Expired - Lifetime DE69930758T2 (de)	1998-09-25	1999-09-24	Verwendung von daptomycin

Country Status (26)

Country	Link
US (2)	US6468967B1 (de)
EP (2)	EP1674107B8 (de)
JP (4)	JP4184607B2 (de)
KR (2)	KR20100051735A (de)
CN (2)	CN1150029C (de)
AT (1)	ATE322280T1 (de)
AU (1)	AU764348B2 (de)
BR (1)	BR9914051A (de)
CA (1)	CA2344318C (de)
CY (3)	CY1105556T1 (de)
DE (3)	DE122006000049I1 (de)
DK (2)	DK1674107T3 (de)
ES (2)	ES2603086T3 (de)
HK (1)	HK1040363B (de)
HU (1)	HU230656B1 (de)
IS (2)	IS5890A (de)
LU (1)	LU91254I2 (de)
NL (1)	NL300232I2 (de)
NO (1)	NO20011454L (de)
NZ (1)	NZ510690A (de)
PL (2)	PL206091B1 (de)
PT (2)	PT1674107T (de)
RU (1)	RU2363489C9 (de)
SI (2)	SI1115417T1 (de)
TR (1)	TR200100841T2 (de)
WO (1)	WO2000018419A2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE122006000049I1 (de)	1998-09-25	2007-01-04	Cubist Pharm Inc	Verwendung von Daptomycin
CN1425025A (zh)	1999-12-15	2003-06-18	卡比斯特制药公司	作为抗菌剂的新颖的脂肽
US6696412B1 (en)	2000-01-20	2004-02-24	Cubist Pharmaceuticals, Inc.	High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en)	2000-12-18	2006-01-19	Dennis Keith	Methods for preparing purified lipopeptides
KR20080036661A (ko) *	2000-12-18	2008-04-28	큐비스트 파마슈티컬즈 인코포레이티드	정제된 리포펩티드의 제조 방법
WO2002059145A1 (en) *	2000-12-18	2002-08-01	Cubist Pharmaceuticals, Inc.	Methods for preparing purified lipopeptides
EP1932853A1 (de)	2001-08-06	2008-06-18	Cubist Pharmaceutical Inc.	Neue Depsipeptide und Herstellungsverfahren dafür
US20040147441A1 (en) *	2002-08-23	2004-07-29	Leach Timothy S.	Methods and reagents for preventing bacteremias
US20050277581A1 (en) *	2002-11-18	2005-12-15	Vicuron Pharmaceuticals Inc.	Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) *	2002-11-18	2006-04-06	Vicuron Pharmaceuticals Inc.	Dalbavancin compositions for treatment of bacterial infections
US20050220862A1 (en)	2004-03-31	2005-10-06	Bernstein Joel E	Compositions with reduced hepatotoxicity
US20060004185A1 (en) *	2004-07-01	2006-01-05	Leese Richard A	Peptide antibiotics and peptide intermediates for their prepartion
US20060014677A1 (en) *	2004-07-19	2006-01-19	Isotechnika International Inc.	Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
US20080051326A1 (en) *	2004-11-12	2008-02-28	Alexander Dylan C	Antiinfective Lipopeptides
US7838532B2 (en) *	2005-05-18	2010-11-23	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
US8524735B2 (en)	2005-05-18	2013-09-03	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
US20070238630A1 (en) *	2006-03-29	2007-10-11	Phillips Douglas H	Subcutaneous skin cleanser
EP2018864A1 (de)	2007-07-23	2009-01-28	Biomet Deutschland GmbH	Pharmazeutische Zusammensetzung, Substrat mit einer pharmazeutischen Zusammensetzung und Verwendung einer pharmazeutischen Zusammensetzung
TW200940552A (en) *	2008-03-04	2009-10-01	Elan Pharm Inc	Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens
PL2320933T3 (pl)	2008-07-17	2018-07-31	Acorda Therapeutics, Inc.	Terapeutyczne dawkowanie neureguliny lub jej subsekwencji do leczenia lub profilaktyki niewydolności serca
DE102008046610A1 (de) *	2008-09-09	2010-03-11	Biomet Deutschland Gmbh	Verwendung einer pharmazeutischen Zusammensetzung zur lokalen Infektionstherapie sowie Medizinprodukt
ES2809177T3 (es)	2008-10-07	2021-03-03	Horizon Orphan Llc	Inhalación de levofloxacino para reducir la inflamación pulmonar
KR20110091510A (ko)	2008-10-07	2011-08-11	엠펙스 파마슈티컬즈, 인코포레이티드	약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
WO2010048630A1 (en)	2008-10-24	2010-04-29	Los Angeles Biomedical Reserch Institute At Harbor-Ucla Medical Center	Anti-infective hydroxy-phenyl-benzoates and methods of use
MX2011006803A (es) *	2008-12-22	2011-09-06	Cubist Pharm Inc	Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas.
TW201035111A (en)	2008-12-23	2010-10-01	Biosource Pharm Inc	Antibiotic compositions for the treatment of gram negative infections
US8450300B2 (en) *	2009-07-13	2013-05-28	Cempra Pharmaceuticals Inc.	Fusidic acid dosing regimens for treatment of bacterial infections
CA2767614C (en) *	2009-07-13	2019-01-15	Cempra Pharmaceuticals Inc.	Fusidic acid dosing regimens for treatment of bacterial infections
CA2938650C (en)	2009-09-04	2018-01-09	Raptor Pharmaceuticals Inc.	Use of aerosolized levofloxacin for treating cystic fibrosis
HUE039967T2 (hu)	2009-11-23	2019-02-28	Cubist Pharmaceuticals Llc	Lipopeptid kompozíció és ezzel kapcsolatos eljárások
US8247394B2 (en)	2010-06-02	2012-08-21	Cempra Pharmaceuticals Inc.	Methods of treating urethritis and related infections using fusidic acid
US8415307B1 (en)	2010-06-23	2013-04-09	Biosource Pharm, Inc.	Antibiotic compositions for the treatment of gram negative infections
US8461188B2 (en)	2011-10-20	2013-06-11	Trius Therapeutics, Inc.	Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
AU2013237939A1 (en)	2012-03-30	2014-10-30	Cubist Pharmaceuticals, Inc.	1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
WO2014041425A1 (en) *	2012-09-11	2014-03-20	Hospira Australia Pty Ltd.	Daptomycin formulations and uses thereof
CN103006562B (zh) *	2013-01-21	2014-09-17	西南大学	达托霉素醇质体制剂
KR102237887B1 (ko)	2013-03-15	2021-04-07	멜린타 서브시디어리 코프.	항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
US11667674B2 (en)	2016-04-08	2023-06-06	Versitech Limited	Antibacterial cyclic lipopeptides
US10647746B2 (en)	2016-04-08	2020-05-12	Versitech Limited	Antibacterial cyclic lipopeptides
JP2019515007A (ja) *	2016-05-13	2019-06-06	スペロポテンシエーターインコーポレイテッドＳｐｅｒｏＰｏｔｅｎｔｉａｔｏｒ，Ｉｎｃ．	新規カチオン性ペプチドｓｐｒ７４１による、抗生物質活性の増強
CN114788814B (zh) *	2021-01-26	2023-10-13	浙江创新生物有限公司	一种高稳定性的注射用达托霉素组合物及其制备方法和其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE32455E (en)	1978-10-16	1987-07-07	Eli Lilly And Company	A-21978 antibiotics and process for their production
USRE32333E (en)	1978-10-16	1987-01-20	Eli Lilly And Company	A-21978 Antibiotics and process for their production
USRE32311E (en)	1982-05-21	1986-12-16	Eli Lilly And Company	Derivatives of A-21978C cyclic peptides
US4524135A (en)	1982-05-21	1985-06-18	Eli Lilly And Company	A-21978C cyclic peptides
US4482487A (en)	1982-05-21	1984-11-13	Eli Lilly And Company	A-21978C cyclic peptides
USRE32310E (en)	1982-05-21	1986-12-16	Eli Lilly And Company	Derivatives of A-21978C cyclic peptides
US4537717A (en)	1982-05-21	1985-08-27	Eli Lilly And Company	Derivatives of A-21978C cyclic peptides
US4885243A (en)	1984-10-09	1989-12-05	Eli Lilly And Company	Process for producing A-21978C derivatives
US4800157A (en)	1985-09-09	1989-01-24	Eli Lilly And Company	Process for producing the A-21978C antibiotics
US4874843A (en)	1987-12-03	1989-10-17	Eli Lilly And Company	Chromatographic purification process
ZA883887B (en)	1987-06-10	1990-02-28	Lilly Co Eli	Chromatographic purification process
ZA901622B (en) *	1989-03-06	1991-11-27	Lilly Co Eli	An improved diluent formulation for daptomycin
FR2755857B1 (fr) *	1996-11-19	1998-12-24	Rhone Poulenc Rorer Sa	Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
FR2772272B1 (fr) *	1997-12-16	2000-01-14	Rhone Poulenc Rorer Sa	Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
DE122006000049I1 (de)	1998-09-25	2007-01-04	Cubist Pharm Inc	Verwendung von Daptomycin
US9393093B2 (en)	2008-02-18	2016-07-19	Covidien Lp	Clip for implant deployment device

1999
- 1999-09-24 DE DE1999630758 patent/DE122006000049I1/de active Pending
- 1999-09-24 DE DE200612000049 patent/DE122006000049I2/de active Active
- 1999-09-24 DK DK06006697.4T patent/DK1674107T3/en active
- 1999-09-24 KR KR1020107006807A patent/KR20100051735A/ko not_active Application Discontinuation
- 1999-09-24 PL PL384274A patent/PL206091B1/pl unknown
- 1999-09-24 US US09/406,568 patent/US6468967B1/en not_active Expired - Lifetime
- 1999-09-24 TR TR2001/00841T patent/TR200100841T2/xx unknown
- 1999-09-24 EP EP06006697.4A patent/EP1674107B8/de not_active Expired - Lifetime
- 1999-09-24 JP JP2000571937A patent/JP4184607B2/ja not_active Expired - Lifetime
- 1999-09-24 CA CA002344318A patent/CA2344318C/en not_active Expired - Lifetime
- 1999-09-24 AU AU62687/99A patent/AU764348B2/en not_active Expired
- 1999-09-24 CN CNB998124982A patent/CN1150029C/zh not_active Ceased
- 1999-09-24 PL PL348328A patent/PL203689B1/pl unknown
- 1999-09-24 ES ES06006697.4T patent/ES2603086T3/es not_active Expired - Lifetime
- 1999-09-24 AT AT99949913T patent/ATE322280T1/de active
- 1999-09-24 PT PT60066974T patent/PT1674107T/pt unknown
- 1999-09-24 DK DK99949913T patent/DK1115417T3/da active
- 1999-09-24 NZ NZ510690A patent/NZ510690A/xx not_active IP Right Cessation
- 1999-09-24 DE DE69930758T patent/DE69930758T2/de not_active Expired - Lifetime
- 1999-09-24 CN CNA200410031708XA patent/CN1530136A/zh active Pending
- 1999-09-24 BR BR9914051-9A patent/BR9914051A/pt not_active Application Discontinuation
- 1999-09-24 KR KR1020017003735A patent/KR20010075327A/ko not_active Application Discontinuation
- 1999-09-24 EP EP99949913A patent/EP1115417B1/de not_active Revoked
- 1999-09-24 PT PT99949913T patent/PT1115417E/pt unknown
- 1999-09-24 SI SI9930904T patent/SI1115417T1/sl unknown
- 1999-09-24 HU HU0103874A patent/HU230656B1/hu unknown
- 1999-09-24 WO PCT/US1999/022366 patent/WO2000018419A2/en active IP Right Grant
- 1999-09-24 ES ES99949913T patent/ES2259845T3/es not_active Expired - Lifetime
- 1999-09-24 SI SI9931082A patent/SI1674107T1/sl unknown
2001
- 2001-03-14 IS IS5890A patent/IS5890A/is unknown
- 2001-03-22 NO NO20011454A patent/NO20011454L/no not_active Application Discontinuation
2002
- 2002-01-09 HK HK02100152.2A patent/HK1040363B/zh not_active IP Right Cessation
- 2002-02-20 US US10/082,544 patent/US6852689B2/en not_active Expired - Lifetime
2003
- 2003-05-27 JP JP2003149968A patent/JP2003321389A/ja not_active Withdrawn
2004
- 2004-03-04 RU RU2004106569/14A patent/RU2363489C9/ru active
- 2004-08-17 JP JP2004237765A patent/JP2004339238A/ja not_active Withdrawn
2006
- 2006-04-18 CY CY20061100536T patent/CY1105556T1/el unknown
- 2006-06-23 NL NL300232C patent/NL300232I2/nl unknown
- 2006-06-28 LU LU91254C patent/LU91254I2/fr unknown
- 2006-07-18 CY CY200600003C patent/CY2006003I2/el unknown
- 2006-09-22 JP JP2006258107A patent/JP2006335773A/ja not_active Withdrawn
2009
- 2009-03-10 IS IS8807A patent/IS8807A/is unknown
2016
- 2016-11-24 CY CY20161101219T patent/CY1118334T1/el unknown

Also Published As

Publication number	Publication date
IS8807A (is)	2009-03-10
NL300232I1 (nl)	2006-09-01
RU2363489C2 (ru)	2009-08-10
PT1674107T (pt)	2016-12-07
ES2603086T3 (es)	2017-02-23
CY2006003I1 (el)	2009-11-04
SI1115417T1 (sl)	2006-08-31
BR9914051A (pt)	2001-06-19
LU91254I2 (fr)	2006-08-28
RU2363489C9 (ru)	2010-03-20
DK1115417T3 (da)	2006-07-31
CN1530136A (zh)	2004-09-22
JP2002525335A (ja)	2002-08-13
EP1115417B1 (de)	2006-04-05
ATE322280T1 (de)	2006-04-15
JP2004339238A (ja)	2004-12-02
KR20010075327A (ko)	2001-08-09
DK1674107T3 (en)	2016-12-19
EP1674107A8 (de)	2006-10-04
HK1040363A1 (en)	2002-06-07
WO2000018419A3 (en)	2000-07-06
NO20011454L (no)	2001-05-25
EP1674107B1 (de)	2016-08-24
US6852689B2 (en)	2005-02-08
EP1674107A2 (de)	2006-06-28
JP4184607B2 (ja)	2008-11-19
NZ510690A (en)	2002-10-25
CY2006003I2 (el)	2009-11-04
CY1105556T1 (el)	2010-07-28
KR20100051735A (ko)	2010-05-17
HUP0103874A3 (en)	2002-09-30
PT1115417E (pt)	2006-07-31
PL206091B1 (pl)	2010-06-30
CY1118334T1 (el)	2017-06-28
EP1115417A2 (de)	2001-07-18
HUP0103874A2 (hu)	2002-02-28
PL203689B1 (pl)	2009-11-30
PL348328A1 (en)	2002-05-20
US20020142948A1 (en)	2002-10-03
TR200100841T2 (tr)	2002-01-21
EP1674107A3 (de)	2012-06-20
SI1674107T1 (sl)	2017-01-31
CN1348382A (zh)	2002-05-08
HK1040363B (zh)	2007-01-26
AU764348B2 (en)	2003-08-14
HU230656B1 (hu)	2017-06-28
DE69930758D1 (de)	2006-05-18
DE69930758T2 (de)	2007-04-26
IS5890A (is)	2001-03-14
NO20011454D0 (no)	2001-03-22
DE122006000049I2 (de)	2007-11-08
CA2344318A1 (en)	2000-04-06
JP2003321389A (ja)	2003-11-11
CN1150029C (zh)	2004-05-19
NL300232I2 (nl)	2007-01-02
AU6268799A (en)	2000-04-17
WO2000018419A2 (en)	2000-04-06
ES2259845T3 (es)	2006-10-16
RU2004106569A (ru)	2005-08-10
CA2344318C (en)	2006-07-04
EP1674107B8 (de)	2017-01-25
JP2006335773A (ja)	2006-12-14
US6468967B1 (en)	2002-10-22

Publication	Publication Date	Title
ATE322280T1 (de)	2006-04-15	Verwendung von daptomycin
DK0713701T3 (da)	2000-04-03	2-Brommelatonin til behandling af søvnforstyrrelser
DE69432984D1 (de)	2003-09-04	Therapeutische substituierte guanidine
ATE260658T1 (de)	2004-03-15	Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
DK0583421T3 (da)	1999-11-22	Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse
DK1201246T3 (da)	2009-02-23	Anvendelse af trombopoietin som et medikament til behandling og forebyggelse af trombocytopeni
ES2160643T3 (es)	2001-11-16	Composiciones que contienen g-csf y proteina de union al tnf.
ES2106531T3 (es)	1997-11-01	Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
IL136733A0 (en)	2001-06-14	Pharmaceutical composition containing sibutramine and orlistat
GB2331926A (en)	1999-06-09	Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
HUP0000110A2 (hu)	2000-06-28	Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények
DE69626050D1 (de)	2003-03-06	Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
SE9803623D0 (sv)	1998-10-22	New therapeutic application